Saturday, May 30, 2026
ADVT 
International

UK opens second ballot for Young Professional visa scheme for Indians

Darpan News Desk IANS, 25 Jul, 2023 11:42 AM
  • UK opens second ballot for Young Professional visa scheme for Indians

London, July 25 (IANS) The UK government has announced the opening of the second ballot of the Young Professional Scheme for Indian citizens between 18 to 30 years of age.

The ballot, which opened on Monday, will close at 1.30 p.m. on Thursday, the British High Commission announced in a tweet.

The scheme, formally launched this year, allows Indian citizens with a graduate or postgraduate qualification to live and work in the UK for up to two years.

It allows the candidate to enter the UK at any time while their visa is valid, and leave and come back at any time during their stay. T

here are 3,000 places available for the India Young Professionals Scheme visa in 2023.

While most places were given in the first ballot which opened in February, the remaining places will be given in the July ballot.

Successful candidates in the ballot need to apply for their visa by the deadline given in a subsequent invitation to apply, which is usually within a month's period.

Also, they must travel to the UK within six months of applying for their visa.

The application fee charges have been set at 259 pounds and additional costs involved is a 940-pound healthcare surcharge and proof that the applicant has 2,530 pounds in personal savings.

To be eligible for the Young Professionals Scheme visa one must be an Indian national or citizen between 18 and 30 years old and have 2,530 pounds in savings to support themselves in the UK.

Also applicants should not have children under the age of 18 living with them or who they are financially responsible for.

MORE International ARTICLES

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports

EU regulator starts safety review of coronavirus drug

EU regulator starts safety review of coronavirus drug
In a statement on Friday, the EU regulator said it isn’t clear whether remdesivir was causing the “acute kidney injury,” but that the issue “warrants further investigation.”

EU regulator starts safety review of coronavirus drug